Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study

D. King, M. Knapp, P. Thomas, D. Razzouk, J. Y. Loze, H. J. Kan, M. Van Baardewijk

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: STAR study'. Together they form a unique fingerprint.

Medicine & Life Sciences